• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Pre-existing cardiac disease and cardiopulmonary RT dose associate with cardiac death in lung cancer

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Abravan, Azadeh
    Faivre-Finn, Corinne
    Banfill, Kathryn
    McWilliam, Alan
    Van Herk, Marcel
    Affiliation
    The University of Manchester/ The Christie NHS Foundation Trust, Division of Cancer Sciences/Radiotherapy Related Research, Manchester,
    Issue Date
    2020
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective Cardiopulmonary toxicity is an adverse event following thoracic RT. It has generally been studied with overall survival as endpoint and without correcting for preexisting cardiac disease (PCD). In this work we identified anatomical regions where the received RT dose correlates with cardiac death (CD), taking PCD into account. Material and Methods 1917 lung cancer patients treated with curative-intent RT (55Gy in 20 fractions) between 2010 and 2016 from a single institution were studied. Primary end point was CD occurring after day 1 of RT and scored based on relevant WHO-ICD10 codes on medical certificate of cause of death from Public Health England data. PCD were collected from Hospital Episode Statistics data prior to RT. To identify the most sensitive anatomical region matched cohort imagebased data-mining was used. Two groups were defined with propensity score matching (1:2, caliper=0.2): patients who died of CD and patients who didn’t – matched on age, tumor volume, PCD and presence of infectious disease/pneumonitis prior to RT. To identify regions where dose correlates with CD, all dose matrices were aligned to a randomly chosen reference patient, mean dose distributions calculated for the matched groups and regions of significant difference detected. In the analyses, the whole cohort was used and those patients with cause of death recorded as ‘cancer’ only were treated as censored. Cumulative incidence estimates of CD, with other-causes of death as a competing risk, were compared by 2-sided p-value using Fine and Gray competing risk regression. Results From a total of 1653 deaths, 1243 patients had cause of death, PCD, and images available. Of these 377 died of known non-cardiac causes, and 175 of cardiac causes. PCD was present in 419 patients (34%). There was an increased risk of CD in patients with PCD (HR=4.24; p<0.001), with 2- year cumulative incidence estimates of 27% compared to 8% (Fig. 1A). Data mining identified a ‘heart-region’ close to the right atrium and a ‘lung-region’ peripheral in the right lung where dose was significantly higher for CD at 1 year (Fig. 2). After adjusting for sex, age, tumor volume,performance status, N stage, histology, and other-causes of death as a competing risk, for patients without PCD the mean dose to the heart-region (>10Gy) was associated with a higher risk of CD (adjusted HR=2.8; p<0.001, Fig. 1B). In patients with PCD, higher mean dose to the lung-region (as continuous variable) was associated with a higher risk of CD (adjusted HR=1.02; p=0.02, Conclusion Patients with PCD are at higher risk of CD. In patients without PCD, dose to the right atrium correlates with risk of CD. In patients with PCD, peripheral right lung dose seems to have the largest impact on CD in line with literature on pulmonary hypertension. The absence of an effect of heart dose in this group may be due to the existing high risk of cardiac events, making it difficult to detect a further increase in the incidence of CD. Additionally there may be a positive effect of ongoing cardiac treatment/monitoring.
    Citation
    Abravan A, Faivre-Finn C, Banfill K, McWilliam A, Van Herk M. OC-0226: Pre-existing cardiac disease and cardiopulmonary RT dose associate with cardiac death in lung cancer. Radiotherapy and Oncology . 2020 Nov;152:S116–7.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/624322
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.